Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX3 | P56373 | 9/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | XIAP | P98170 | 2/20 | 0.33 |
| ▸ | NPY1R | P25929 | 1/20 | 0.33 |
| ▸ | SRC | P12931 | 3/20 | 0.33 |
| ▸ | CCKBR | P32239 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26961711 | 1.00 | P2RX3 (0.36) | P2RX3POLBMAPTXIAPNPY1R | |
| SCHEMBL26961897 | 0.86 | MAPT (0.41) | P2RX3POLBMAPTXIAPNPY1R | |
| SCHEMBL26962161 | 0.85 | CA1 (0.36) | P2RX3POLBMAPTXIAPNPY1R | |
| SCHEMBL26961911 | 0.85 | P2RX3 (0.34) | P2RX3POLBMAPTXIAPNPY1R | |
| SCHEMBL31143107 | 0.83 | MAPT (0.39) | P2RX3POLBMAPTXIAPNPY1R | |
| SCHEMBL26962800 | 0.83 | MAPT (0.39) | P2RX3POLBMAPTXIAPNPY1R | |
| SCHEMBL26961775 | 0.83 | MAPT (0.39) | P2RX3POLBMAPTXIAPNPY1R | |
| SCHEMBL29796935 | 0.83 | MAPT (0.39) | P2RX3POLBMAPTXIAPNPY1R | |
| SCHEMBL20264163 | 0.82 | POLB (0.42) | P2RX3POLBMAPTXIAPNPY1R | |
| SCHEMBL27131652 | 0.82 | POLB (0.42) | P2RX3POLBMAPTXIAPNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4291558-A1 | BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER | F. Hoffmann-La Roche AG (CH) | 2023-12-20 | — | — | EP | disclosed |
| WO-2022171745-A1 | BICYCLIC TETRAHYDROAZEPINE DERIVATIVES FOR THE TREATMENT OF CANCER | F. HOFFMANN-LA ROCHE AG (CH) | 2022-08-18 | — | — | WO | disclosed |